ARGX argenx N.V. Total Asset Value of Company
This price visualization of argenx SE (ARGX) total assets shows a value of 8603.11. The business focuses on developing high-yield FcRn inhibitors to combat rare pathologies. ESG principles are integrated into trial ethics and laboratory ecology. The strategic vector is aimed at releasing a universal antibody-based treatment capable of curing multiple severe autoimmune disorders.
Analytical breakdowns and data insights for company Argenx (ARGX)
- stock quotes and analyst forecast:
- market capitalization data:
- issuer book value statistics:
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio argenx SE|ARGX - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio argenx BVBA|ARGX - Company Aggregate Debts|Debts to Book Capitalization argenx BVBA|ARGX - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings argenx|Interim Coverage Ratio argenx.com
- net income and valuation multiples indicators:
Fundamental valuation:argenx SE
The scale of operations at argenx SE is determined by the volume of resources deployed in the development of innovative drugs. This metric is reverse-calculated via return on assets (ROA), reflecting the aggregate of equity and external liabilities. It measures the overall material base of the business, which, amid the geopolitical stability of the biotech sector, is growing without sanction risks. An analysis of historical balance sheet assets allows for an assessment of the efficiency of the company's infrastructure expansion.
Key competitors
Total Business Assets BNTX|Aggregate Company Assets abivax.com|ADMA Biologics Inc - Total Asset Value of Company|Company Total Assets PTGX|IMVT (Immunovant Therapeutics) - Aggregate Asset Value|Company Total Assets KNSA (Kiniksa Pharmaceuticals)|Company Total Assets grifols.com GRFS|ADPT - Aggregate Company Assets|Aggregate Asset Value CLDX (Celldex Therapeutics Inc)|Aurinia Pharma (AUPH) - Aggregate Company Assets|Cumulative Company Assets BioCryst Corp|VERA (Vera Therapeutics, Inc.) - Company Total Assets|Company Total Assets dianthustx.com|Cumulative Company Assets PHVS (Pharvaris)|ABCL (AbCellera Biologics) - Aggregate Asset Value|Company Total Assets TRML (Tourmaline Corp)|Company Total Asset Base Precigen Corp (PGEN)|PHAR - Aggregate Company Assets|nektar.com (NKTR) - Cumulative Company Assets|Upstream Bio (UPB) - Aggregate Company Assets|Cumulative Company Assets Zenas Bio|Cumulative Company Assets IMNM|Company Total Assets Gossamer Bio Corp.|Aggregate Company Assets KalVista Pharmaceuticals (KALV)|septerna.com - Total Business Assets|Company Total Assets PVLA (Pieris Pharmaceuticals, Inc.)|Savara Inc (SVRA) - Company Assets|Rigel Pharmaceuticals Inc - Company Total Assets|ANAB - Company Total Assets|Astria Therapeutics (ATXS) - Aggregate Company Assets|engene.com - Aggregate Asset Value|RAPT (RAPT Therapeutics) - Company Total Assets|JBIO - Company Balance Sheet Assets|Company Total Assets ACRS|KYTX - Company Assets|Aggregate Company Assets Tiziana Life Sciences TLSA|CABA: Total Business Assets|VTYX: Cumulative Company Assets|THTX (Theratechnologies, Inc.) - Total Business Assets|AVTX (Avalo Therapeutics Inc.) - Cumulative Company Assets|Eledon Pharmaceuticals, Inc - Aggregate Asset Value|Aggregate Company Assets Agenus|climbbio.com (CLYM) - Company Total Asset Base|Company Total Assets ZURA|ATYR - Company Assets|Company Total Assets ADAG (Adagene Inc.)|Company Total Assets ImageneBio IMA|STTK - Aggregate Company Assets|Aggregate Asset Value EQ (Equillium, Inc.)|CNTB: Company Total Assets|Company Balance Sheet Assets Immunic IMUX|Cumulative Company Assets ATRA|Total Business Assets IFRX (InflaRx GmbH)|Aggregate Company Assets X4 Pharmaceuticals (XFOR)|ACET: Total Asset Value of Company|Company Total Assets CELU (Celularity)|Aggregate Asset Value INMB|Barinthus Bio - Company Total Assets|KZR - Company Total Assets|SAB Biotherapeutics (SABS) - Aggregate Company Assets|akaritx.com - Aggregate Asset Value|Aggregate Company Assets Enlivex Therapeutics Ltd|Cumulative Company Assets Q32 Bio Corp (QTTB)|Company Total Assets GOVX|Company Total Assets Edesa Biotech Corp (EDSA)|iBio, Inc. - Cumulative Company Assets|Aggregate Asset Value CARM|XTL Biopharmaceuticals Ltd. - Company Total Assets|Company Total Asset Base Bolt Biotherapeutics BOLT|hcwbiologics.com (HCWB) - Aggregate Company Assets|Cumulative Company Assets Aptevo Therapeutics Inc.|Aggregate Company Assets AIM ImmunoTech Inc.|Cumulative Company Assets Aditxt Corp (ADTX)|Cumulative Company Assets GRI (GRI Bio)|Company Total Assets XORTX Therapeutics Inc (XRTX)|Aggregate Company Assets ReShape Lifesciences HIND|REVB: Total Business Assets|Indaptus Therapeutics - Company Total Assets|Company Assets scinai.com|CALI: Company Total Assets|Affimed N.V. (AFMD) - Company Total Assets|Aggregate Company Assets Allakos Inc|HOOK: Aggregate Asset Value|Company Total Assets IGMS|iteostherapeutics.com (ITOS) - Company Balance Sheet Assets|Company Total Assets OCEA (Ocean Biomedical)|TC BioPharm (Holdings) Plc (TCBP) - Company Assets|THRD - Aggregate Company Assets